Mauck CK - Search Results

1

As the world grows: contraception in the 21st century.

Aitken RJ, Baker MA, Doncel GF, Matzuk MM, Mauck CK, Harper MJ. Aitken RJ, et al. Among authors: mauck ck. J Clin Invest. 2008 Apr;118(4):1330-43. doi: 10.1172/JCI33873. J Clin Invest. 2008. PMID: 18382745 Free PMC article. Review.

2

Biomarkers of semen in the vagina: applications in clinical trials of contraception and prevention of sexually transmitted pathogens including HIV.

Mauck CK, Doncel GF; Biomarkers of Semen Exposure Clinical Working Group. Mauck CK, et al. Contraception. 2007 Jun;75(6):407-19. doi: 10.1016/j.contraception.2007.02.007. Epub 2007 Apr 30. Contraception. 2007. PMID: 17519146 Review.

3

Use of contraceptive depot medroxyprogesterone acetate is associated with impaired cervicovaginal mucosal integrity.

Zalenskaya IA, Chandra N, Yousefieh N, Fang X, Adedipe OE, Jackson SS, Anderson SM, Mauck CK, Schwartz JL, Thurman AR, Doncel GF. Zalenskaya IA, et al. Among authors: mauck ck. J Clin Invest. 2018 Oct 1;128(10):4622-4638. doi: 10.1172/JCI120583. Epub 2018 Sep 17. J Clin Invest. 2018. PMID: 30222141 Free PMC article. Clinical Trial.

4

TSPY4 is a novel sperm-specific biomarker of semen exposure in human cervicovaginal fluids; potential use in HIV prevention and contraception studies.

Jacot TA, Zalenskaya I, Mauck C, Archer DF, Doncel GF. Jacot TA, et al. Contraception. 2013 Sep;88(3):387-95. doi: 10.1016/j.contraception.2012.11.022. Epub 2012 Dec 7. Contraception. 2013. PMID: 23312930

5

Cervical inflammation and immunity associated with hormonal contraception, pregnancy, and HIV-1 seroconversion.

Morrison C, Fichorova RN, Mauck C, Chen PL, Kwok C, Chipato T, Salata R, Doncel GF. Morrison C, et al. J Acquir Immune Defic Syndr. 2014 Jun 1;66(2):109-17. doi: 10.1097/QAI.0000000000000103. J Acquir Immune Defic Syndr. 2014. PMID: 24413042

6

An Update on Vaginal Microbicides.

Mauck C, Doncel G. Mauck C, et al. Curr Infect Dis Rep. 2001 Dec;3(6):561-568. doi: 10.1007/s11908-001-0095-3. Curr Infect Dis Rep. 2001. PMID: 11722815

7

Vaginal microbicides: a novel approach to preventing sexual transmission of HIV.

Doncel G, Mauck C. Doncel G, et al. Curr HIV/AIDS Rep. 2004 Apr;1(1):25-32. doi: 10.1007/s11904-004-0004-0. Curr HIV/AIDS Rep. 2004. PMID: 16091220 Review.

8

Biomarker discovery: validation and decision-making in product development.

Niedbala RS, Mauck C, Harrison P, Doncel GF. Niedbala RS, et al. Sex Transm Dis. 2009 Mar;36(3 Suppl):S76-80. doi: 10.1097/OLQ.0b013e31819cd800. Sex Transm Dis. 2009. PMID: 19218888 Review.

9

The Contribution of Cervicovaginal Infections to the Immunomodulatory Effects of Hormonal Contraception.

Fichorova RN, Chen PL, Morrison CS, Doncel GF, Mendonca K, Kwok C, Chipato T, Salata R, Mauck C. Fichorova RN, et al. mBio. 2015 Sep 1;6(5):e00221-15. doi: 10.1128/mBio.00221-15. mBio. 2015. PMID: 26330510 Free PMC article.

10

The Effect of Hormonal Contraception on Cervicovaginal Mucosal End Points Associated with HIV Acquisition.

Thurman A, Chandra N, Schwartz JL, Brache V, Chen BA, Asin S, Rollenhagen C, Herold BC, Fichorova RN, Hillier SL, Weiner DH, Mauck C, Doncel GF. Thurman A, et al. AIDS Res Hum Retroviruses. 2019 Sep;35(9):853-864. doi: 10.1089/AID.2018.0298. Epub 2019 May 14. AIDS Res Hum Retroviruses. 2019. PMID: 30997816 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

96 results

Search Page